Nutrien Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 5 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien or view top-rated stocks.

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Nutrien saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 3,320,000 shares, a decrease of 30.7% from the February 28th total of 4,790,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is presently 1.7 days. Approximately 0.6% of the shares of the company are short sold.
View Nutrien's Short Interest.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Nutrien.

Nutrien will be holding an earnings conference call on Monday, May 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nutrien Ltd. (NYSE:NTR) released its quarterly earnings results on Wednesday, February, 17th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.15 by $0.09. The firm earned $4.05 billion during the quarter, compared to analysts' expectations of $3.58 billion. Nutrien had a trailing twelve-month return on equity of 4.19% and a net margin of 0.47%.
View Nutrien's earnings history.

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NTR stock has increased by 75.1% and is now trading at $56.02.
View which stocks have been most impacted by COVID-19.

Nutrien announced a quarterly dividend on Friday, February 19th. Stockholders of record on Wednesday, March 31st will be given a dividend of $0.46 per share on Thursday, April 15th. This represents a $1.84 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date of this dividend is Tuesday, March 30th. This is an increase from Nutrien's previous quarterly dividend of $0.35.
View Nutrien's dividend history.

Nutrien pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.18%. Nutrien does not yet have a strock track record of dividend growth. The dividend payout ratio of Nutrien is 82.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Nutrien will have a dividend payout ratio of 79.65% in the coming year. This indicates that Nutrien may not be able to sustain their current dividend.
View Nutrien's dividend history.

Nutrien updated its FY 2021 After-Hours earnings guidance on Wednesday, February, 17th. The company provided earnings per share guidance of 2.05-2.75 for the period.

13 brokerages have issued twelve-month price objectives for Nutrien's shares. Their forecasts range from $44.00 to $66.00. On average, they anticipate Nutrien's stock price to reach $56.44 in the next year. This suggests a possible upside of 0.8% from the stock's current price.
View analysts' price targets for Nutrien or view top-rated stocks among Wall Street analysts.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), CVR Partners (UAN), Bioceres Crop Solutions (BIOX), Marrone Bio Innovations (MBII), Calyxt (CLXT), Evogene (EVGN), Wynnstay Group (WYN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), Eden Research (EDEN) and Kiwa Bio-Tech Products Group (KWBT).
View all of NTR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include QV Investors Inc. (0.17%), Miller Howard Investments Inc. NY (0.13%), Hexavest Inc. (0.03%), Cardinal Capital Management Inc. (0.02%), WealthTrust Axiom LLC (0.02%) and Livingston Group Asset Management CO operating as Southport Capital Management (0.01%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Livingston Group Asset Management CO operating as Southport Capital Management, Signature Wealth Management Group, Hexavest Inc., WealthTrust Axiom LLC, Crossmark Global Holdings Inc., and Pacifica Partners Inc..

NTR stock was purchased by a variety of institutional investors in the last quarter, including Miller Howard Investments Inc. NY, QV Investors Inc., Cardinal Capital Management Inc., Fruth Investment Management, Harbour Capital Advisors LLC, NEXT Financial Group Inc, and Vigilant Capital Management LLC.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NTR stock can currently be purchased for approximately $56.02.

Nutrien has a market capitalization of $31.94 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis.

Nutrien employs 23,100 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien is headquartered at SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]